Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Altabrisa Group
AddedFeb 16, 2024
UpdatedJun 18, 2026
Altabrisa Group

Altabrisa Group

Series C

Altabrisa Group: A global consultancy firm offering tailored GXP services in pharmaceuticals, medical devices, and biotech.

HQ
New York City, NY, US
Overview
Compare
Fundraising
Employees

Altabrisa Group is a global consultancy firm specializing in pharmaceuticals, medical devices, and biotechnology. They provide tailored GXP consulting services, including GCP, GLP, and GMP compliance. Their mission is to deliver high-quality, customized solutions to meet regulatory and quality standards across the healthcare industry.

Altabrisa Group has achieved recognition for its comprehensive quality and regulatory compliance consulting services. Their impact is marked by successful collaborations with various healthcare organizations, ensuring adherence to stringent industry standards and facilitating market access for innovative medical products.

Altabrisa Group - Similar Companies

GXP Consultants logo

GXP Consultants

Arbour Group logo

Arbour Group

arbourgroup.com

Pharmapotheca A logo

Pharmapotheca A

chemapotheca.com

Alterra Medical logo

Alterra Medical

alterramedical.com

BrilliMedical International logo

BrilliMedical International

Altesa logo

Altesa

altesabio.com

AlphaLab Health logo

AlphaLab Health

alphalabhealth.org

ABC Laboratories logo

ABC Laboratories

abclabs.com

Quintiles logo

Quintiles

quintiles.com

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

AmericanPharma Technologies logo

AmericanPharma Technologies

Accelerated Vision Group logo

Accelerated Vision Group

Abpro logo

Abpro

Facet Life Sciences logo

Facet Life Sciences

ABio-X logo

ABio-X

abio-x.com

Altabrisa Group - Quick Facts

Who are Altabrisa Group's competitors?

Companies similar to Altabrisa Group include GXP Consultants, Arbour Group, Pharmapotheca A and Alterra Medical.

Where is Altabrisa Group's headquarters located?

Altabrisa Group's headquarters is located in New York City, NY, US.

When was Altabrisa Group's last funding round?

Altabrisa Group's most recent funding round was for $940k (USD) in April 2014.

How much has Altabrisa Group raised to-date?

As of Apr 8, 2014, Altabrisa Group has raised a total of $1.4M (USD).

How many employees does Altabrisa Group have?

Altabrisa Group has 5 employees as of Feb 4, 2024.

Altabrisa Group - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Consulting
  • Services
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research